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ABSTRACT 
 
 
QUANTIFICATION AND CHARACTERIZATION OF BIOLOGICALLY ACTIVE 
COMPONENTS OF ACTAEA RACEMOSA L. (BLACK COHOSH) FOR 
IDENTIFYING DESIRABLE PLANTS FOR CULTIVATION 
 
Patrick Michael Looney  
Western Carolina University (Summer 2012) 
Director: Dr. Jason Clement 
 
Actaea racemosa, more commonly known as black cohosh, is a medicinal plant used for 
the suppression of menopausal symptoms. The growing popularity of black cohosh 
extract is leading to extensive wild harvesting of the perennial plant. The main purpose of 
this research is to use high-pressure liquid chromatography evaporative light scattering 
detection analysis of 20 accessions of black cohosh from Bent Creek Germplasm 
Repository to quantify the compounds with desirable biological activities. Plants 
identified as having desirable properties may be used to produce a superior hybrid plant. 
Cultivation of the hybrid plant may help black cohosh’s sustainability. This research 
showed that there were significant differences in phytochemical concentratio s among 
the accessions.   
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INTRODUCTION  
 
 
 Actaea racemosa, more commonly known as black cohosh, is a medicinal plant 
used for the suppression of menopausal symptoms.1 Black cohosh is a plant native to the 
eastern United States and can be found as far south as Georgia, west into parts of 
Missouri, and even into Ontario, Canada.  Black cohosh is found along moist creek 
banks, meadows, forest, and ravines and can be found locally in the Blue Ridge Parkway 
corridor and the Great Smoky Mountains.1,2 The growing popularity of black cohosh 
extract is leading to extensive wild harvesting of the perennial plant. As with all natural 
resources, once the natural supply is gone, it is gone forever. To help preserve these 
natural products, cultivars of superior black cohosh plants could be established by local 
farmers.  
  The research project was funded by the North Carolina Biotechnology Center. 
The overall goal of the grant is to develop a regional cultivar of hybrid black cohosh 
plants to stimulate economic development in Western North Carolina. This grant funds a 
collaboration of multiple groups working on specific aspects of the overall project. Our 
collaborators at Bent Creek Germplasm Repository (BCGR) are responsible for 
collection, harvesting and measurements of growth characteristics for the plant 
accessions. Our collaborators in the Western Carolina University Biology Department, 
Cullowhee, NC are performing genetic marker analysis and genetic stud es. The main 
purpose of this master’s research is to use high-pressure liquid chromatography with 
evaporative light scattering detection analysis of 20 accessions of black cohosh from Bent 
Creek Germplasm Repository to quantify compounds with desirable biological activities 
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in hopes to produce a superior hybrid plant to decrease wild harvesting. The secondary 
purpose of this research is to isolate and characterize novel compounds from black 
cohosh plants from BCGR.  
  To accomplish the above task, standards must be isolated and characterized from 
black cohosh. The chromatography methods used in this research were modified from 
published articles. Once the methods were optimized, calibration standards were mad  
and analyzed in triplicate. The calibration response was a second-degree polynomial 
because the polynomial gave the best coefficient of correlation. All of the raw sample 
data was transferred to Microsoft Excel for ANOVA analysis. The hypothesis for this 
research is that in the BCGR collection there will be significant chemical differences 
between accessions. 
   
BACKGROUND 
 
 
 Menopause, as defined by the World Health Organization, is the permanent 
cessation of menstruation due to the loss of ovarian follicular activity.3 The result of this 
loss of ovarian follicular activity causes hormone levels to fluctuate.4 During menopause, 
the level of estrogen in the body decreases, due to the ovaries gradually stopping the 
production of estrogen as the egg supply decreases.5 Symptoms associated with 
decreasing estrogen levels in the body include hot flashes, mood swings, depression, 
sleep disturbances, bone loss and loss of libido.1 
Compounds found in black cohosh can help suppress some of the symptoms 
associated with low estrogen levels. The exact mechanism by which black cohosh 
provides menopausal relief has not been fully elucidated. However, available research 
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supports black cohosh as an effective treatment for the suppression of some menopausal 
symptoms, especially hot flashes.1 Other studies show black cohosh having an inhibitory 
effect on the hypothalamus.6 The hypothalamus plays a role in the regulation of the 
temperature of the body, as a result, inhibiting parts of the hypothalamus could alleviate 
hot flashes. Other published studies demonstrated that black cohosh affects the estrogen 
receptors (ER). 7 Estrogen receptors are sites where estrogen binds in a biological system. 
Recent studies have shown that there are correlations between therapeutic activity and the 
presence of the cycloartane triterpene glycosides (saponins) and estrogenic activit es 
associated with the presence of the aromatic acids.26 Also, the aromatic acids have been 
reported to have anti-inflammatory properties associated with rheumatism brought upon 
by menopause.1, 27, 28 
 Black cohosh contains many classes of compounds, but the five types of 
compounds of interest are: cycloartane triterpene glycosides,1, 2 aromatic acids, 
isoflavones, dopamine-type derivatives, and cimipronidine-type alkaloids.9 The two types 
of natural products that are the focus of the current study are the triterpene glycosides and 
the aromatic acids. It is unclear if isoflavones are actually present in black cohosh. 
Isoflavones have been reported by Jarry et al.,8 however, the presence of isoflavones has 
not been confirmed in other published studies.11,12 Examples of cycloartane triterpene 
glycosides found in black cohosh are actein (1), 23-epi-26-deoxyactein (2), 
cimiracemoside A (3), cimiracemoside C (4), acetyl shengmanol xyloside (5), and 26-
deoxycimicifugoside (6). Examples of the aromatic acids are caffeic acid (7), isoferulic 
acid (8), and ferulic acid (9).10 An example of an isoflavone is formononetin (10). An 
interesting note about formononetin is that although it has been reported to have 
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estrogenic activity, 11 it has not been identified in black cohosh samples from the United 
States.11,12 
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Previous studies show that alcoholic extracts of black cohosh have been 
successful in treating hot flashes.13 Other studies show that actein, a triterpene glycoside, 
could act as selective estrogen receptor modulator (SERMs), which might explain how 
actein could have estrogen-modulating effects in the hypothalamus, but not in the 
uterus.14 The hypothalamus is the area of the brain that produces hormones for the 
regulation of body temperature, sex drive, sleep, thirst hunger, moods, and release of 
hormones from other glands.15 The Rhyu et al.16 study stated that alcoholic extracts of 
black cohosh had constituents with an affinity for the human opiate receptors (HMOR). 
This is also noteworthy because the opiate receptor system affects several aspects of 
female reproductive neuroendocrinology, such as the control of sex hormones. Bodinet et 
al.17 showed that growth of human breast adenocarcinoma cells (MCF-7) was 
significantly inhibited by black cohosh extract added to tamoxifen indicating that black 
cohosh could be used to suppress menopausal symptoms associated with breast cancer. 
Powell et al.18 have identified Nω-methylserotonin (11), which is a known 5-HT agonist, 
as a potential active constituent of black cohosh extract.  
 
 
 
 
       
   Historically, black cohosh has been used medicinally to treat many illnesses. 
Native North Americans used black cohosh for malaria, rheumatism, abnormalities in 
kidney function, sore throat, menstrual complaints, tuberculosis, as an analgesic, as a 
N
H
NH
OH
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sedative, and as a stimulant.1 Black cohosh has also been used in pain relief associated 
with aching muscles, arthritis, and child birth.1 Finding out information about the 
mechanism would be exciting because then the plant could potentially be used in cancer 
research. Black cohosh is classified by the German Health Authority (Commission E) as 
a nonprescription drug to treat neurovegetative symptoms associated with menopause 
(i.e. hot flashes).1 Neurovegetative refers to the section of the nervous system that 
controls involuntary functions. 
               Black cohosh has been heavily wild-harvested for the rhizome material. Wild 
harvesting of black cohosh makes up 90% of material used in trade.1 There are many 
problems associated with this practice, such as adulteration with potentially toxic species 
and high chemical variation among harvests. The largest suppliers of wild harvested 
black cohosh rhizome material are located in the southeastern United States.1 There are 
other species in the genus Actaea or Cimicifuga, which are similar to black cohosh and 
are common adulterants found in commercial black cohosh. These other species of plants, 
A. pachypoda, A. podocarpa, and A. rubifolia, have different chemical compositions and 
biological properties.1  
 Black cohosh is ranked among the top ten best-selling dietary supplements in the 
United States.19   Western North Carolina would be a suitable environment for the growth 
of black cohosh crops, providing high economic returns per acre. The possible 
identification of plant accessions that contain high levels of biologically active 
compounds will help in identifying plants that can be developed into a superior hybrid 
that could be grown in Western North Carolina.  This would help to reduce or stop wild 
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harvesting of the plant, which would assist in making black cohosh production more 
sustainable.  
There have been previous studies researching the phytochemical variations among 
different accessions of black cohosh using high-pressure liquid chromatography 
evaporative light scattering detection.20 One study by Al-Amier et al. only had a small 
number of plants with little geographic diversity. In contrast, this study has twenty 
accessions of plants from thirteen different states. Studying more accessions over a wide 
geographic range may increase the chances of finding plants with superior prope ties. 
The Al-Amier et al. study did not have closely-controlled growing conditions. The plants 
in this study were grown under strictly controlled conditions. The novel aspect in 
comparison to others is that no one has ever studied a large collection of black cohosh 
grown under identical conditions. The large number of accessions may show many 
chemical differences which could lead to the development of a superior hybrid plant for 
cultivation.   
INSTRUMENT BACKGROUND 
 
 
         High-pressure liquid chromatography (HPLC) is the main analytical te hnique used 
in this phytochemical study. HPLC is a column chromatography technique that iswidely 
used. The HPLC system is a Dionex Ultimate 3000. The Dionex system has solvent 
reservoirs, a pump (which contains an in-line degasser and mixing station), refrigerated 
autosampler, temperature controlled column compartment, a 4-channel ultraviole 
detector, and an evaporative light scattering detector.  The entire system is managed by 
Dionex Chromeleon software.             
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          Ultraviolet and evaporative light scattering detectors were used. The Dion x UV 
detector is a multiple channel detector, collecting data from four different analytical 
wavelengths ranging from the visible to ultraviolet. The detector measures the attenuation 
of light, at a specific wavelength, by the compounds eluting from the column. This 
follows Beer’s Law (A = bc) where A is the absorbance, ǫ is the extinction coefficient, 
c is the concentration and b is the pathlink. A point worth noting about the UV detector is 
that it is non-destructive and gives a linear response. However, at high concentrations the 
UV response can be nonlinear. Triterpene glycoside compounds do not absorb well in the 
ultraviolet range because they have poor chromophores. Therefore, for the purpose of this 
research another means of detection is needed. 
         The evaporative light scattering detector (ELSD) is the detector of choice for 
triterpene glycosides. The ELSD that was used for this research is a Varian 380 LC. The 
eluent from the UV detector is carried to the ELSD nebulizer. In the nebulizer, the luent 
is mixed with a nitrogen carrier gas. The nitrogen gas and the eluent mixture form an 
aerosol plume of uniform droplets, which moves on to the evaporator. Larger droplets 
will collect in the nebulizer waste chamber, which empties into a collecti n bottle. The 
atomized spray is carried through the evaporation tube towards the laser light source 
with the help of the dry nitrogen flow. Any residual solvent is evaporated off, leaving  
stream of dry particles of the analyte. Laser radiation then impinges on the streaming 
particles. The scattered radiation by the analyte is detected at a righ ngle to the flow by 
a silicon photodiode. Scattering caused by solvent is taken as a background signal at the 
start of the analysis. 
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           The intensity of scattered light is dependent on the number of analyte particles and 
the analyte particle size. The scattering depends on the radius of the analytparticle (r) 
compared to the wavelength (λ) of incident light. Mie scattering occurs when r/λ is 
greater than 5x10-2. Rayleigh scattering is predominant when r/λ is less than 5x10-2.34 In 
Mie scattering most of the scattered light is projected in the direction of incident light, 
whereas in Rayleigh scattering the scattering is in all directions. Generally, the amount of 
light scattered is proportional to the power 4 (Mie) or 6 (Rayleigh) of the radius of the
analyte particle.33 Mie scattering is dominant; however both Mie and Rayleigh can occur 
within the ELSD. Figure 1 (below) is a depiction of the two scattering mechanisms.    
Figure1: Scattering mechanisms34 
 
Mie Rayleigh 
Direction of incident light
 
 
 ELSD response to concentration is sample dependent,  
    A = a m b                  (Eq.1) 
where A is the peak area,  is the response factor unique to the analyte, m is the analyte 
concentration, and b is an exponent ranging from 4 for Mie scattering, to 6 for Rayleigh 
scattering. Recent articles have shown that in practice the power is closer to 5,12 most 
likely the result of both Mie and Rayleigh scattering contributing to the response. For 
convenience Eq. 1 can be written as 29-32 
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           log    log  	 log 
               
   (Eq.2) 
When log A is graphed as a function of log m, the slope is equal to the exponent (b) in Eq. 
1. However, since response is sample dependent, some samples can be better modeled as 
a polynomial function.40, 12 The literature suggests that the response of the detector 
depends on the parameters of that specific detector.40, 12 ELSD data appears to follow a 
sigmoidal regression, however at low concentrations a second-degree polynomial or a 
power function can be used to model the regression. In the present study, the coefficient 
of determination is slightly better with a second-degree polynomial than a power 
function, therefore the second-degree polynomial was used.  The major advantage to 
using this detector is that it can be used to detect a wide range of non-UV absorbing 
compounds. There are downsides to this detection: it is a destructive technique, it 
requires a nitrogen carrier gas, and variation of response depends on mobile phase 
composition. 
EXPERIMENTAL 
 
 
 Instrumentation. 
 
 
The HPLC system that was used for the quantitative analysis was a Dionex 
Ultimate 3000 equipped with both a Dionex 4-channel UV detector and Varian 
evaporative light scattering detector (380-LC). The column used was a Phenomenex 
Kinetex (4.6 x 100mm, 2.6µm particle size, 100 Å, C18).  
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The isolation half of the project used the same HPLC system mentioned above for 
sample checks. A JEOL 300 MHz NMR was used to collect all of the carbon and proton 
spectra for the isolation of standards. A Perkin Elmer HPLC pump was used for both 
preparative and semi-preparative HPLC. The semi-preparative HPLC column that was 
used was a Varian Dynamax (250 x 10 mm, Microsorb 100-5, C-18) equipped with an 
Agilent Dynamax guard column (Microsorb 100-5, C-18). The preparative column is a 
Varian Dynamax (250 x 21.4 mm, Microsorb 100-5, C-18) equipped with a Varian guard 
column (1 inch, Microsorb 100-5, C-18).  A Dionex Ultimate 3000 coupled with a 
ThermoFinnigan LTQ Linear Ion Trap mass spectrometer with an electrospray ionization 
source (ESI) was used to collect low resolution mass spectrometric data.  
CHEMICALS 
 
 
Chemicals used in this project are listed, along with the manufacturer, in Table 1. 
Table 1: Chemicals Used During Analysis 
Chemical Manufacturer  
HPLC Methanol Pharmco-Aaper 
HPLC Dichloromethane Pharmco-Aaper 
HPLC Chloroform Pharmco-Aaper 
d5- Pyridine Cambridge Isotope Laboratories Inc. 
d-Chloroform Acros Organics 
Trifluoroacetic acid Fisher Scientific 
Formic Acid Fisher Scientific 
HPLC Hexanes  Fisher Scientific 
HPLC Acetonitrile Pharmco-Aaper 
Nitrogen Andy-oxy 
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PLANT PROPAGATION 
 
 
The plants in this study were grown from wild-harvested rhizome material from 
twenty accessions of plants from 13 states (AR, DE, IN, KY, MD, MO, NC, NY, PA, SC, 
TN, VA, WV). The term “accession” refers to plants collected at a particular geographic 
location. The rhizome material was planted and allowed to grow at the BCGR for three 
years under identical environmental conditions with USDA barcode labels to maintain 
sample identity at BCGR. Once the plants matured, they were transplanted to 7’× 7’× 20’ 
controlled-pollination screen cages from Redwood Empire Awning Company. All 
pertinent information about the accessions is available from the Germplasm Resource 
Information Network (GRIN) database.21 All of all the above work was performed by 
Joe-Ann McCoy and collaborators at BCGR.  
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RHIZOME PREPARATION 
 
 
 After collection, the rhizomes where pressure sprayed with water to ensure that 
the rhizomes were clean. After washing, the rhizomes were placed in a drawer with a 
screened bottom in a cabinet containing a dehumidifier to dry. The material was then cut 
with pruning shears into 3-4 cm pieces and separated into different populations before 
milling in a Thomas Wiley Mini-Mill. The ground material was weighed both before and 
after drying. The mill was cleaned after each plant sample was milled. The mill was 
vacuumed and blown out via an air compressor. The glass front was cleaned with alcohol 
to ensure no plant material was left. The above work was performed by Sara Pate at 
BCGR and WCU.   
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ANALYTICAL METHODS 
 
 
SAPONINS 
 
 
 Method 1. 
 
 
Method 1 was the first of two methods for detecting the triterpene saponins (1, 2, 
3, 4, 5, 6). The flow rate for method 1 was 1.0 ml/min and the injected amount of sample 
was 20 µl. The mobile phase is composed of a gradient of acetonitrile (ACN) and 0.1% 
formic acid (FA) aqueous (Time: 0 min, 30% ACN, 70% of 0.1% FA aqueous, 15 min, 
40% ACN, 60% of 0.1% FA aqueous, 30 min, 60% ACN, 40% of 0.1% FA aqueous, 45 
min, 30% ACN, 70 % of 0.1% FA aqueous). The ELSD is the means of detecting the 
triterpene glycosides (1, 2). ELSD parameters: Nebulizer temperature 55oC, Evaporator 
temperature 90oC, PMT gain of 5 and gas flow of 1.60 SLM. The run time is 55 minutes. 
The column used is a Phenomenex Kinetex at a controlled temperature of 25 oC.  
Method 1 was used primarily for the isolation of the standards. Method 1 served 
as a way to check that the desirable compounds was present in a sample and used to 
determine relative purity of the sample. The raw rhizome material, provided by BCGR 
was extracted and analyzed via method 1. The analysis showed that there were co-eluting 
peaks around the retention time of two of the compounds of interest.  Method 2 was 
developed to resolve the co-eluting peaks. Method 2 is like the original method with a 
sharp initial gradient from 10% ACN to 30 % ACN over 10 minutes.   
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 Method 2. 
  
 
Method 2 was used for detecting the triterpene saponins (1, 2, 3, 4, 5, 6). The flow 
rate for method 2 was 1.0 ml/min. The injected amount of sample was 20 µl.  The mobile 
phase is a gradient of acetonitrile (ACN) and 0.1% formic acid aqueous (FA) (Time: 0 
min, 10% ACN, 90% of 0.1% FA aqueous, 10 min, 30% ACN, 70% of 0.1% FA 
aqueous, 30 min, 40% ACN, 60% of 0.1% FA aqueous, 45 min, 60% ACN, 40% 0.1% 
FA aqueous, 46 min, 10 %ACN, 90% of 0.1% FA aqueous, 55 min, 10% ACN, 90% of 
0.1% FA aqueous). The ELSD is the means of detecting the triterpene glycosides. ELSD 
parameters: Nebulizer temperature 55oC, Evaporator temperature 110oC, PMT gain of 5 
and gas flow of 1.60 SLM. The run time is 55 minutes. The column used is a 
Phenomenex Kinetex at a controlled temperature of 25 oC.  
Method 2 was used for the quantitative analysis part of this project. This method 
was developed because of a peak co-eluting peak with 23-epi-26-deoxyactein. Method 2 
was needed due to extraction differences probably from solvent changes in comparis n to 
the literature. The flow rate was increased to 1 ml/min from the original 0.5 ml/min. The 
major change to the method was the addition of the initial 10% ACN to 30% ACN. 
Lowering the starting acetonitrile concentration then ramping up to 30% acetonitrile over 
ten minutes separated the co-eluting peaks.       
PHENOLIC ACIDS 
 
 
 The phenolic acids method was used for quantifying the aromatic acids (7, 8, and 
9). The solvent flow rate is 1.0 ml/min. The mobile phase is composed of acetonitrile 
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(ACN) and 0.05% trifluoroacetic acid (TFA) in water. The solvent system for the 
phenolic acids compounds was a gradient (0 min, 5% ACN, 95% of 0.05% TFA aqueous, 
5 min, 10% ACN, 90% of 0.05% TFA aqueous, 15 min, 30 % ACN, 70% of 0.05% TFA 
aqueous, 16 min, 100% ACN, 21 min, 100% ACN, 22 min, 5% ACN, 95% of 0.05% 
TFA aqueous, 32 min, 5% ACN, 95% TFA). The means of detection was the ultraviolet 
detector set at 254 nm. The run time of the method is 32 minutes and the injected amount 
is 10µl. The column used was a Phenomenex Kinetex. 
 The phenolic acids method, as in the saponin method, was also optimized.12 
Initially, peak shapes of the phenolic acids compounds were not sharp. The injection 
volume was cut to 10 µl and the peak shape sharpened. The first phenolic acids method 
was an isocratic method. Since the gradient method worked for the saponins a gradient 
method was implemented here. However, the use of a gradient method increased the 
analysis time but the resolution and sharpness of the peaks increased as well. In 
comparison to other published methods these methods gave the best resolution relative to 
other methods attempted.12 
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ANALYTICAL SAMPLE PREPARATION 
 
 
 The plant material samples were all individually wrapped and labeled, 54 in total. 
From each sample, 1.00 ± 0.01 g was placed into a 50 ml centrifuge tube. To the tube, 40 
ml of a 1:1 ethanol:water (v/v) solution was added. The extraction mixture was allowed 
to shake on an orbital shaker for 24 hours. The sample was filtered through a Whatman 
0.45µm PTFE filter and placed into a glass HPLC sample vial before analysis.   
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ANALYTICAL STANDARD PREPARATION 
 
 
Calibration standards were needed to quantify the concentrations of the aromatic 
acids and the triterpene glycosides. Standard solutions were made up in varying 
concentrations of 10, 20, 40, 60, 80 and 100µg/ml. All of the standards were analyzed by 
both the saponin and phenolic acids methods. All of the standard solutions were analyzed 
in triplicate. The information obtained from all of the runs were placed into a excel 
spreadsheet where calibration equations and R2 were calculated. The “y” in the 
polynomial equation refers to average peak area and “x” refers to concentration (ppm) 
area. All calibration information is listed in Table 2. 
 
 
Table 2: Calibration Information of all of the Standards 
Compound Equation  R2 
Actein y = 0.003x2 + 0.147x - 1.534 0.9991 
23-epi-26-Deoxyactein y = 0.005x2 + 0.415x - 2.968 0.9997 
Cimiracemoside C y = 0.005x2 + 0.058x - 0.340 0.9997 
Cimiracemoside A y = 0.010x2 + 0.136x - 0.985 0.9993 
Deoxycimicifugoside  y = 0.007x2 + 0.353x - 6.869 0.9998 
Acetyl Shengmanol Xyloside y = 0.003x2 + 0.083x - 1.438 0.9990 
Caffeic Acid y = 0.343x + 0.744 0.9960 
Ferulic Acid y = 0.396x – 2.147 0.9991 
Isoferulic Acid y = 0.410x – 3.222 0.9997 
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RECOVERY ANALYSIS 
 
 
 From wild harvested black cohosh material from BCGR, (106A169A) 1.003 g of 
crude rhizome material was weighed out and placed into a 50 mL centrifuge tube. The 
rhizome material was extracted with 40 ml of a 1:1 ethanol:water (v/v) solution and 
sonicated for 30 minutes. After sonication, the extract was filtered and HPLC-UV-ELSD 
analysis was performed. The above procedure was repeated until no peaks were seen in 
the UV and ELSD chromatograms. 
 The exhaustively-extracted rhizome material was split into two samples for 
analysis. Half of the material (0.432 g) was used for a blank. The other 0.501 grams of 
rhizome material contained 1 ml of a working standard solution of 23-epi-26-deoxyactein 
(510 ppm) and ferulic acid (810 ppm). The rhizome material was dried under argon, re-
extracted, and analyzed via HPLC-UV-ELSD by both the saponin and phenolic acid 
methods. Both of the samples were analyzed in triplicate.       
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LIMIT OF DETECTION AND QUANTIFICATION 
 
 
 The limit of detection was determined by triangulation of the lowest concentratio  
to determine the area.39 The triangulation formula is Area= ½ x Base x Height. The base 
is the mean peak width of the lowest concentration standard. The height is equal to the 
noise of a blank, which was determined by analysis of the blank in triplicate, at th  
specific time of the eluting standard multiplied by 3.39 The noise level was calculated by 
the Chromeleon software. This area was used to calculate the limit of detection for each 
of the standards respectively39. The limit of quantification was calculated as mentioned 
above with the height equaling 10 x noise.  
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STATISTICS 
 
 
 To determine if there are any statistical differences in the concentratio s of the 
saponins and phenolic acids between different accessions of plants, a single factor 
ANOVA analysis was performed. Before ANOVA analysis all the data for each 
compound by accession was converted to weight percentages and averaged in Microsoft 
Excel.    
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ISOLATION OF STANDARDS 
 
 
Crude black cohosh rhizome material was collected and processed by Bent Creek 
Germplasm Repository. The rhizome powder (219.100 g) (106A066A) rhizome powder 
was extracted with 500 mL of a 1:1 dichloromethane:methanol (v/v) mixture for 24 hours 
at room temperature. This solution was filtered and 500 mL of methanol was added to the 
powder. The methanol extraction was sonicated for 30 minutes and the solution was dried 
under vacuum to yield 14.104 grams of extract (106A066C). 
The crude extract was dissolved in 900 mL of 60% aqueous methanol, which was 
washed with 3 portions of hexanes (300 mL) to yield a hexane fraction (106A067B, 
1.685 g). To the initial 60% methanol aqueous layer 180 mL of water was added to dilute 
the methanol concentration to 50%. The 50% methanol aqueous solution was then 
washed with 3 portions of chloroform (360 mL) to yield the chloroform fraction 
(106A067C, 5.464 g). The remaining 50% methanol aqueous solution was dried under 
vacuum to remove the methanol. The remaining water solution (540 mL) was washed 
with 3 portions of 1-butanol (180 mL) to yield a 1-butanol fraction (106A067E, 4.402 g). 
The water layer was freeze dried to yield a water fraction (106A067D, 2.448g).  
ISOLATION OF CIMIRACEMOSIDE A 
 
 
The chloroform fraction (106A067C) was fractionated further by an open C18 step 
gradient column. The solvent system for the column was 50%-100% methanol followed 
by 100% chloroform. The column was a glass filter frit column with dimensions 9.5 cm 
tall by 4.5 cm wide. The column was packed with 220 grams of C18 packing material. 
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The step gradient gave seven fractions (106A069A-G). After checking all samples by 
LCMS, fraction 106A069C (615.33 mg) was chosen for further purification.  
To further purify fraction 106A069C (1.218g), a silica gel step gradient open 
column technique was used. The solvent system consisted of a step gradient using 19:1, 
9:1, 4:1, 2:1 chloroform:methanol (v/v) mixtures followed by a 100% methanol flush 
(400 mL fractions). This step gradient gave 5 fractions (106A072A-E). After LCMS 
analysis, fraction 106A072B had the compound of interest. The next step in the isolation 
was an HP20 open column. The HP20 (80 grams) separation gave nine fractions 
(106A080A-I).  The solvent system was a step gradient from 20%-100% methanol (330 
mL each fraction). The column was 4.5 cm wide by 11 cm high and the sample was dry 
loaded. Dry loading refers to the sample absorbed to the column packing material before 
elution. The 106A080A-I series of fractions were analyzed by HPLC-ELSD. The analysis 
showed that fractions 106A080D-I were similar. The fractions were recombined 
(106A080J) for further purification.  
 Fraction 106A080J was purified by preparative HPLC. The peak of interest 
eluted in 20 minutes. The ELSD detector was used in the detection of cimiracemoside A, 
therefore a splitter was used to split the flow in two directions. The splitter setup was a 
three way splitter with a 2 cm piece of orange tubing (high flow) and a 20 cm piece of 
black tubing (low flow to detector). The solvent system was 30% acetonitrile and 70%  
0.1%  formic acid aqueous, the sample concentrations was 250 mg/mL, the flow rate was 
10 mL/min, the injected volume was 25µL (total mass injected 320 mg), and the ELSD 
settings were nebulizer: 55°C, evaporator: 110°C, gas flow: 1.60 SLM, and the gain was 
set to 1. This preparative isolation was performed twice and gave 12 fractions 
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(106A088A-F and 106A090A-F). The purity of the sample was checked via the 
Phenomenex Kinetex analytical column on the Dionex HPLC, LCMS, carbon NMR, and 
proton NMR.  
 All of the fractions were analyzed by LCMS. Fraction 106A088A and 106A090A 
had the compound of interest. Fraction 106A090A was further purified by non-end 
capped C18 reverse phase semi-preparative HPLC to yield 8.15 mg of cimiracemoside A 
(106A113C) and 5.04 mg of cimiracemoside F (106A113B).35 The solvent system was an 
isocratic 37% acetonitrile 63% of a 0.1% formic acid aqueous, the flow rate was 2 
mL/min, the sample concentrations was 14 mg/mL, the injected volume was 2µL (total 
mass injected 29.61mg), and the ELSD settings were nebulizer: 55°C, evaporator: 110°C, 
gas flow: 1.60 SLM, and the gain was set to 5.  
Fraction 106A088A was further purified by C18 reverse phase preparative HPLC. 
The solvent system was 37% acetonitrile 63% 0.1% formic acid aqueous, the sample 
concentrations was 14 mg/mL, the flow rate was 10 mL/min, the injected volume was 
25µL (total mass injected 44.06 mg), and the ELSD settings were nebulizer: 55°C, 
evaporator: 110°C, gas flow: 1.60 SLM, and the gain was set to 5. Preparative HPLC 
gave 1.93 mg of cimiracemoside A. The purity of the same was checked via the 
analytical column on the Dionex HPLC, LCMS, carbon NMR, and proton NMR.   
Additional cimiracemoside A was purified from fraction 106A069A (504.97 mg). 
To further purify 106A069A a silica gel step gradient open column technique was used. 
The solvent system for this column was a 19:1, 9:1, 4:1, 2:1 chloroform: methanol 
mixture followed by a 100% methanol flush (192 mL each fraction). This step gradient 
gave 5 fractions (106A104A-E). After LCMS analysis, fraction 106A104B had the 
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compound of interest. Fraction, 106A104B, was further purified by C18 reverse phase 
preparative HPLC. The solvent system was 40% acetonitrile 60% 0.1% formic acid 
aqueous, the sample concentrations was 250 mg/mL, the flow rate was 10 mL/min, the 
injected volume was 25µL (total mass injected 76.94 mg), and the ELSD settings were 
nebulizer: 55°C, evaporator: 110°C, gas flow: 1.60 SLM, and the gain was set to 1. 
Preparative HPLC separation was preformed twice to give nine fractions (106A106A-D 
and 106A107A-D).  
Fractions 106A106C and 106A107C were combined for semi-preparative HPLC 
purification (106A107E). This sample was further purified by non-end capped C18 
reverse phase semi-preparative HPLC to yield 1.48 mg of cimiracemoside A 
(106A108C). The solvent system was an isocratic 37% acetonitrile 63%  0.1% formic 
acid aqueous, the flow rate is 2 mL/min, the sample concentrations was 14 mg/mL, the 
injected volume was 2µL (total mass injected 6.39 mg), and the ELSD settings were 
nebulizer: 55°C, evaporator: 110°C, gas flow: 1.60 SLM, and the gain was set to 5.   
ISOLATION OF CIMIRACEMOSIDE C AND CIMIGENOL XYLOSIDE 
 
 
To further purify fraction 106A069D (708.91 mg), a silica gel (35 grams) step 
gradient open column technique was used. The solvent system for this column was a step 
gradient using 19:1, 9:1, 4:1, 2:1 chloroform:methanol (v/v) mixture followed by a 100% 
methanol flush (380 mL fractions). The column dimensions are 3.5 cm wide by 12.5 cm 
high. This step gradient gave 5 fractions (106A111A-E). After LCMS analysis, fraction 
106A111B had the compounds of interest. Fraction106A111B was further purified by C18
reverse phase preparative HPLC. The solvent system was 35% acetonitrile 65% 0.1% 
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formic acid aqueous, the sample concentration was 250 mg/mL, the flow rate was 10 
mL/min, the injected volume was 25µL (total mass injected 376.27 mg) , and the ELSD 
settings were nebulizer: 55°C, evaporator: 110°C, gas flow: 1.60 SLM, and the gain was 
set to 1.  The separation gave three fractions (106A114A-C).  
Fraction 106A114A (197.59 mg) was further purified again by C18 reverse phase 
preparative HPLC. The solvent system was 40% acetonitrile 60% of 0.1% formic acid n
water, the sample concentrations was 250 mg/mL, the flow rate was 10 mL/min, the 
injected volume was 25µL (total mass injected 197.59 mg), and the ELSD settings were 
nebulizer: 55°C, evaporator: 110°C, gas flow: 1.60 SLM, and the gain was set to 1. The 
separation gave two fractions (106A117A-C). Fraction 106A117C (10 mg) was 
confirmed to be cimiracemoside C, and fraction 106A117D (9.62 mg) was confirmed to 
be cimigenol xyloside by LCMS, proton NMR, and by carbon NMR.  
ISOLATION OF ACETYL SHENGMANOL XYLOSIDE 
 
 
To further purify fraction 106A069B (615.33 mg), a silica gel step gradient open 
column technique was used. The solvent system for this column was a step gradient using 
19:1, 9:1, 4:1, 2:1 chloroform:methanol (v/v) mixture followed by a 100% methanol flush 
(240 mL fractions). This step gradient gave 5 fractions (106A092A-E). After LCMS 
analysis, fraction 106A092B had the compound of interest. Fraction 106A092B, was 
further purified by C18 reverse phase preparative HPLC. The solvent system was 35% 
acetonitrile 65%  0.1% formic acid in water, the sample concentrations was 250 mg/mL, 
the flow rate was 10 mL/min, the injected volume was 25µL (total mass injected 170.96 
mg), and the ELSD settings were nebulizer: 55°C, evaporator: 110°C, gas flow: 1.60 
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SLM, and the gain was set to 1.  The prep-HPLC separation gave two fractions 
(106A093A-B). Fraction 106A093B (13.12 mg) was confirmed to be acetyl shengmanol 
xyloside by LCMS, proton NMR, and by carbon NMR. 
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ISOLATION: RESULTS AND DISCUSSION 
 
 
CIMIRACEMOSIDE A 
 
 
 Cimiracemoside A gave a base peak signal of 659.18 m/z ([M+H-H2O]) in 
positive mode low resolution ESI-MS. To further confirm the identity of cimiracemoside 
A both proton and carbon NMR techniques were used. Since the compound is not soluble 
in chloroform, all of the NMR analysis was performed using d5 pyridine as the solvent. 
Table 5 is the tabulated data for the NMR analysis in comparison to published data for 
the compound.  The carbon spectrum showed the expected signals. The spectrum also has 
the acetate ester signal at δ 170.95 ppm and the double bond signals at δ 148.00 and δ 
114.21 ppm. The data also shows signals for the oxygenated carbons between δ 67-88 
ppm. All experimental carbon NMR data corresponds well to that found in the literature. 
Those results are found in Table 3. 
CIMIRACEMOSIDE C 
 
 
 Cimiracemoside C showed after positive mode ESI-MS analysis a peak at 621.36 
m/z which is the molecule plus hydrogen. The mass to charge ratio matches that of the 
Shao data for cimiracemoside C. Carbon NMR analysis reveals a good correlation 
between the experimental data and the published data. The carbon data suggest that th re 
are oxygenated carbons with the signals between δ59.3-90 ppm. The only double bond in 
the compound shows up at δ 107.82 ppm and δ 112.35 ppm, which is agrees with the 
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Shao data.   All experimental carbon NMR data corresponds well to that found in the 
literature. Those results are found in Table 3. 
Table 3: Carbon NMR data for Cimiracemoside A and Cimiracemoside C 
 
 
 
 
 
 
 3    4  
Position δC
a (Shao) δC
a (exp)  Position δC
a (Shao) δC
a (exp) 
1 30.50 30.50  1 32.70 32.80 
2 29.80 29.84  2 30.30 30.44 
3 88.20 88.21  3 88.90 88.96 
4 40.70 40.75  4 41.60 41.71 
5 42.70 42.78  5 47.90 47.96 
6 22.10 22.10  6 21.40 24.46 
7 114.20 114.21  7 26.60 26.81 
8 148.00 148.00  8 48.90 48.99 
9 21.50 21.95  9 20.30 21.44 
10 28.60 28.59  10 26.90 27.57 
11 37.00 37.04  11 26.70 27.03 
12 77.00 77.01  12 34.40 34.44 
13 49.10 49.09  13 42.10 42.23 
14 51.30 51.31  14 47.60 47.66 
15 42.30 42.29  15 80.50 80.58 
16 72.60 72.60  16 112.20 112.34 
17 53.60 53.31  17 59.80 59.93 
18 15.40 15.38  18 19.90 20.37 
19 29.00 29.03  19 31.20 31.24 
20 34.60 34.58  20 24.40 25.78 
21 17.90 17.89  21 19.80 19.95 
22 87.00 87.01  22 38.40 38.52 
23 106.00 106.05  23 72.10 72.19 
24 83.60 83.63  24 90.40 90.55 
25 84.00 83.99  25 71.20 71.31 
26 28.30 28.32  26 25.70 26.11 
27 25.20 25.25  27 26.00 26.72 
28 27.00 27.04  28 12.10 12.17 
29 26.00 26.06  29 27.50 30.34 
30 14.50 14.58  30 15.70 19.88 
1’ 107.80 107.83  1’ 107.70 107.82 
2’ 75.90 75.98  2’ 73.20 73.32 
3’ 79.00 79.01  3’ 74.90 75.01 
4’ 71.60 71.60  4’ 69.70 69.88 
5’ 67.50 67.49  5’ 67.00 67.10 
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CIMIGENOL XYLOSIDE 
 
 
 Cimigenol xyloside (12) gave in ESI-MS a signal at 621.13 m/z ([M+H]). The 
mass spectrum also appears to show sodium adduct at 643.47 ([M+23]). The 
experimental carbon NMR data shows 35 total carbons with 9 oxygenated carbons (δ 67 
ppm- δ 90.5 ppm) which match the Jamroz data. All experimental carbon NMR data 
corresponds well to that found in the literature. Those results are found in Table 4.   
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ACETYL SHENGMANOL XYLOSIDE 
 
 
 ESI-MS analysis of acetyl shengmanol xyloside revealed a peak at 645.45 m/z 
which correlates to the molecule losing a water molecule ([M+H-H2O]). The loss of 
water in ESI-MS is commonly observed with these types of compounds.38 The 
experimental carbon NMR data shows 37 carbons, agrees with Kusano’s data. The 
experimental carbon data suggest that there are 2 carbonyl carbons (δ 170.98 ppm & δ 
220.34 ppm) and 8 oxygenated carbons all together, which match the Kusano reference. 
All experimental carbon NMR data corresponds well to that found in the literature. Those 
results are found in Table 4. 
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Table 4: Cimigenol Xyloside and Acetyl Shengmanol Xyloside Carbon data 
 
 12      5      
Position δC
a (Jamroz) δC
a (exp)    Position δC
a (Kusano) δC
a (exp)     
1 32.70 32.82    1 32.20 32.60     
2 30.30 30.50    2 30.00 30.45     
3 88.90 88.60    3 88.40 88.77     
4 41.60 41.75    4 41.30 41.70     
5 47.90 48.00    5 47.50 47.83     
6 21.40 21.45    6 21.00 21.32     
7 26.60 26.76    7 26.70 27.14     
8 48.90 49.02    8 48.20 48.61     
9 20.30 20.40    9 20.10 20.45     
10 26.90 27.06    10 26.80 28.31     
11 26.70 26.80    11 26.00 27.04     
12 34.40 34.45    12 33.00 33.40     
13 42.10 42.26    13 41.50 41.90     
14 47.60 47.68    14 46.10 46.45     
15 80.50 80.60    15 82.90 83.29     
16 112.20 112.37    16 219.58 220.34     
17 59.80 59.96    17 60.00 60.31     
18 19.90 19.96    18 19.80 20.15     
19 31.20 31.27    19 30.50 30.84     
20 24.40 24.48    20 28.00 30.33     
21 19.80 19.90    21 20.30 20.68     
22 38.40 38.55    22 37.00 37.33     
23 72.10 72.23    23 72.10 72.45     
24 90.40 90.50    24 65.20 65.51     
25 71.20 71.64    25 58.50 58.89     
26 25.70 25.80    26 24.70 26.03     
27 26.00 26.12    27 19.30 19.69     
28 12.10 12.20    28 12.00 12.33     
29 27.50 27.58    29 25.70 26.33     
30 15.70 15.83    30 15.40 15.80     
1' 107.70 107.98    COCH3 170.50 170.98     
2' 73.20 75.98    COCH3 21.53 25.05     
3' 74.90 79.01    1’ 107.40 107.93     
4' 69.70 71.34    2’ 74.60 78.98     
5' 67.00 67.52    3’ 72.90 75.93     
      4’ 69.50 71.61     
      5' 65.70 67.48     
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    QUANTITATIVE ANALYSIS 
 
 
 The main purpose of the quantitative analysis was to identify desirable black 
cohosh plant accessions for cultivation. A desirable plant is one that has the highest 
concentrations of the triterpene saponins. All 54 samples were analyzed via both the 
saponin and phenolic acid methods. The extraction procedure was the same for all of the 
samples. The samples were analyzed in triplicate. The peak areas were transf rred to 
Microsoft Excel for data analysis. In Excel all the data was converted to weight percent 
and averaged. 
RECOVERY ANALYSIS 
 
 
 The two sets of recovery samples were analyzed via HPLC-UV-ELSD by both the 
saponin and phenolic acids methods. Both of the samples were analyzed in triplicate. The 
average recovery that was observed for 23-epi-26-deoxyactein was 98.79%, and for 
ferulic acid the recovery was 91.06%. This data shows that the extraction method and the 
analysis methods are accurately measuring saponin and phenolic acid concentrations.  
 
LIMIT OF DETECTION AND QUANTIFICATION 
 
 
 The limit of detection and quantification for each of the standards are shown in 
table 8 below.  
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Table 5: Limit of Detection & Quantification 
Compound LOD (ng) LOQ (ng) 
Ferulic Acid 109.00 109.40 
Isoferulic Acid 158.60 162.20 
Caffeic Acid 43.60 44.40 
Actein 237.40 349.20 
23-epi-26-Deoxyactein 171.60 254.20 
Cimiracemoside A 130.00 182.00 
Cimiracemoside C 168.80 302.00 
Acetyl Shengmanol Xyloside 280.60 319.80 
Deoxycimicifugoside 321.40 351.00 
 
ANOVA ANALYSIS 
 
 
 The null hypothesis for the ANOVA was that there will not be chemical 
differences between plant accessions. A significant difference oc urs when F >Fcrit with a 
p-value less than 0.05. If a significant difference is observed, then the data will be further 
investigated. If no difference is seen then no further action is required because the data 
for the compounds concentrations are similar.  For the analysis, all of the data was 
organized by compound, total measured saponin, total measured phenolic acids, and 
actein plus 23-epi-26-deoxyactein. The ANOVA analysis rejected the null hypothesis for 
the total saponins and failed to reject the null hypothesis for the total phenolic acids. The 
ANOVA data only includes the 16 accessions that contained 3 rhizome samples that were 
randomly collected for conformity. 
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TOTAL SAPONIN 
 
 
 The total saponin ANOVA was performed on the sum of all the saponins 
measured for each of the 16 accessions. This was done for each accession and is 
presented in Figure 2. The ANOVA analysis showed that among accessions, the total 
saponin concentrations are significantly different. The F value (6.34) was higher than Fcrit 
(1.99) with a p value of 6.16E-06. The total saponin ANOVA revealed that the null 
hypothesis was rejected. The error bars in Figure 2 represent +/- one standard deviation.   
Figure 2: Total Saponin Weight % by Accession 
 
TOTAL PHENOLIC ACIDS 
 
 
 The ANOVA analysis showed that among the accessions, total phenolic acid 
concentrations are significantly different. The F value (2.7551) was greater th n Fcrit 
(1.992) with a p value of 0.0079. The total phenolic acids ANOVA revealed that the null 
hypothesis was rejected. However, leaving out accession NC4 and performing another 
ANOVA analysis revealed that there is not a significant difference between the total 
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phenolic acids. The ANOVA results show F value (1.8054) was less than Fcrit (2.0374) 
with a p value of 0.0855. NC4 has the highest weight percent of the phenolic acids as 
compared to the other accessions. If the NC4 accession is taken out of the ANOVA 
analysis then the concentrations are similar between accessions. The error bars in Figure 
3 represent +/- one standard deviation. 
Figure 3: Total Phenolic Acids Weight % by Accession 
 
 
ACTEIN AND 23-EPI-26-DEOXYACTEIN 
 
 
 According to Gaia Herbs,36 the triterpene saponins actein and 23-epi-26-
deoxyactein are used to standardize black cohosh preparations. Table 13, in the appendix, 
is the combined data for actein and 23-epi-26-deoxyactein. The ANOVA analysis showed 
that for actein and 23-epi-26-deoxyactein there are significant differences across the 
accessions. The F value (3.177) was higher than Fcrit (1.99) with a p value of 0.0029. The 
Actein and 23-epi-26-deoxyactein ANOVA revealed that the null hypothesis was 
rejected. The error bars in Figure 4 represent +/- one standard deviation.  
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Figure 4: Total Actein and 23-epi-26-Deoxyactein Weight % by Accession 
 
  
 Since industry uses actein and 23-epi 26- deoxyactein concentrations to 
standardize black cohosh products, an accession with the highest levels of actein and 23-
epi-26-deoxactein would be desirable for producing a cultivar. DE2 has the highest total 
concentration of actein and 23-epi-26-deoxyactein. After ANOVA analysis of a subset 
(Table 33 in appendix) of accessions DE2, IN1, PA1, NY2, NC3, KY1, it is apparent that 
there are no differences. Statistically speaking there is no superior accession with high 
concentrations of actein and 23-epi-26-deoxyactein. Figure 4 shows all of the data for 
both actein and 23-epi-26-deoxyactein as weight percent’s and the DE2 plants have the 
highest percent, by weight, of both compounds on average. The error bars in Figure 4 
represent +/- one standard deviation. 
 This is the first study to present data looking at both the triterpene saponins and 
the phenolic acids concentrations for plant accessions in hopes to find a superior 
accession or accessions for potential of developing a region cultivar. The Al-Amier 
reference only refers to a small collection of plants from only five states.20 They only 
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reported data for the phenolic acids (ferulic, isoferulic, caffeic acids). There HPLC 
method was not optimized for the phenolic acid compounds. Instead of having an 80 
minute method they could have modified it to 32 or even 13 minute analysis. The novel 
aspect of this research is that no one has ever studied a large collection of black cohosh 
grown under identical conditions. 
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  CONCLUSION 
 
 
 The purpose of this study was to run evaporative light scattering detection 
analysis of plants from 20 accessions of black cohosh to quantify the compounds with 
desirable biological activities in hopes of producing a superior hybrid plant. The 
hypothesis that there will be phytochemical differences between accessions was 
confirmed.  Although there are significant differences across the collecti n, there are no 
significant differences in a subset of the collection (IN1, PA1, NY2, NC3, KY1, DE2) in 
terms of actein and 23-epi-26-deoxyactein. The NC4 accession has the highest weight 
percent of the phenolic acids. Growth characteristics and phytochemical con entrations 
will be used to identify candidates for breeding studies. The breeding studies have the 
potential to produce a hybrid plants that could produce higher concentrations of 
compounds which then could be grown by local farmers. The plants grown by local 
farmers could be harvested and sold to stimulate the local economy. Hybrid cultivars of 
black cohosh could dramatically change the use of black cohosh in the clinic. These 
plants with higher concentrations of the saponins could lead to a more potent and 
effective supplement.   
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FUTURE STUDIES 
 
 
 Further studies will include developing a regional cultivar of the superior black
cohosh plants in Western North Carolina. Screening of black cohosh extracts for their 
bioactivity is currently being conducted. A future goal is to isolate and purify desirable 
compounds for industry for analytical reference standards. Future studies also involve 
isolating novel biologically active compounds from black cohosh. Once a desirable 
accession has been identified based on growth studies and phytochemical concentrations 
Bent Creek Germplasm Repository plans to implement a breeding program to make a
hybrid plant that maintains the desirable properties. 
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Table 6: Total Actein Content for Each Accession 
 
Table 7: Actein Raw Values (Weight %) 
Accession 1st  2nd 3rd Average 
Standard 
Deviation 
TN1 0.243 0.109 0.254 0.202 0.080 
46/MO 0.121 0.204 0.074 0.133 0.066 
VA1 0.174 0.138 0.232 0.181 0.047 
PA2 0.066 0.173 0.075 0.105 0.059 
68/AR 0.105 0.192 0.104 0.134 0.050 
DE2 0.341 0.367 0.219 0.309 0.078 
NY1 0.191 0.111 0.147 0.150 0.040 
NY2 0.284 0.263 0.205 0.251 0.040 
WV1 0.207 0.164 0.345 0.239 0.094 
NC2 0.294 0.234 0.273 0.267 0.030 
KY1 0.265 0.360 0.301 0.309 0.048 
IN1 0.318 0.233 0.379 0.310 0.073 
NC3 0.371 0.294 0.358 0.341 0.041 
WV2 0.140 0.330 0.219 0.230 0.095 
PA1 0.313 0.191 0.414 0.306 0.111 
NC4 0.156 0.372 0.141 0.223 0.128 
Table 8: ANOVA Analysis Data for Actein 
ANOVA 
Source of Variation SS df MS F P-value F crit 
Between Groups 0.248 15 0.017 3.073 3.73E-03 1.991 
Within Groups 0.172 32 5.38E-03    
Total 0.420 47         
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Table 9: Total 23-epi-26-Deoxyactein Content for Each Accession 
 
Table 10: 23-epi-26-Deoxyactein Raw Values (Weight %) 
Acession 1st 2nd 3rd Average 
Standard 
Deviation 
TN1 0.133 0.134 0.171 0.146 0.021 
46/MO 0.057 0.081 0.040 0.059 0.020 
VA1 0.109 0.104 0.122 0.112 0.009 
PA2 0.080 0.125 0.075 0.093 0.027 
68/AR 0.064 0.070 0.056 0.063 0.006 
DE2 0.256 0.248 0.140 0.215 0.064 
NY1 0.143 0.080 0.106 0.110 0.031 
NY2 0.156 0.149 0.173 0.160 0.012 
WV1 0.129 0.127 0.200 0.152 0.041 
NC2 0.127 0.087 0.125 0.113 0.022 
KY1 0.128 0.156 0.119 0.134 0.019 
IN1 0.174 0.137 0.193 0.168 0.028 
NC3 0.138 0.103 0.144 0.128 0.021 
WV2 0.083 0.155 0.088 0.109 0.039 
PA1 0.197 0.107 0.275 0.193 0.084 
NC4 0.060 0.134 0.052 0.082 0.045 
Table 11: ANOVA Analysis Data for 23-epi-26-Deoxyactein 
ANOVA 
Source of Variation SS df MS F P-value F crit 
Between Groups 0.086 15 5.73E-03 4.207 3.15E-04 1.991 
Within Groups 0.043 32 1.36E-03    
Total 0.129 47         
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Table 12: Total Cimiracemoside A Content for Each Accession 
 
Table 13: Cimiracemoside A Raw Values (Weight %) 
Accession 1st 2nd 3rd Average 
Standard 
Deviation 
TN1 0.122 0.073 0.114 0.103 0.026 
46/MO 0.038 0.047 0.036 0.040 0.006 
VA1 0.073 0.071 0.092 0.079 0.011 
PA2 0.099 0.100 0.075 0.091 0.013 
68/AR 0.040 0.037 0.058 0.045 0.011 
DE2 0.118 0.161 0.135 0.138 0.021 
NY1 0.050 0.065 0.064 0.059 0.009 
NY2 0.077 0.086 0.099 0.087 0.010 
WV1 0.064 0.119 0.090 0.091 0.027 
NC2 0.180 0.176 0.164 0.173 0.008 
KY1 0.073 0.070 0.077 0.073 0.003 
IN1 0.079 0.077 0.075 0.077 0.002 
NC3 0.280 0.218 0.222 0.240 0.034 
WV2 0.062 0.069 0.085 0.072 0.011 
PA1 0.090 0.084 0.104 0.092 0.010 
NC4 0.086 0.085 0.060 0.077 0.014 
Table 14: ANOVA Analysis Data for Cimiracemoside A 
ANOVA 
Source of Variation SS df MS F P-value F crit 
Between Groups 0.112 15 7.50E-03 27.941 3.59E-14 1.991 
Within Groups 0.008 32 2.69E-04    
Total 0.121 47         
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Table 15: Total Deoxycimicifugoside Content for Each Accession 
 
Table 16: 26-Deoxycimicifugoside Raw Values (Weight %) 
Accession 1st 2nd 3rd Average 
Standard 
Deviation 
TN1 0.146 0.097 0.202 0.148 0.052 
46/MO 0.096 0.092 0.073 0.087 0.012 
VA1 0.100 0.095 0.084 0.093 0.008 
PA2 0.093 0.074 0.082 0.083 0.009 
68/AR 0.087 0.086 0.094 0.089 0.004 
DE2 0.130 0.133 0.115 0.126 0.009 
NY1 0.103 0.079 0.077 0.087 0.010 
NY2 0.142 0.118 0.091 0.117 0.025 
WV1 0.092 0.137 0.183 0.137 0.045 
NC2 0.097 0.078 0.086 0.087 0.009 
KY1 0.099 0.112 0.115 0.109 0.008 
IN1 0.075 0.084 0.099 0.086 0.012 
NC3 0.087 0.069 0.083 0.080 0.009 
WV2 0.093 0.095 0.115 0.101 0.012 
PA1 0.122 0.080 0.123 0.108 0.024 
NC4 0.083 0.085 0.077 0.082 0.004 
Table 17: ANOVA Analysis Data for 26-Deoxycimicifugoside 
ANOVA 
Source of 
Variation SS df MS F P-value F crit 
Between Groups 0.020 15 1.34E-03 2.960 0.005 1.991 
Within Groups 0.014 32 4.55E-05    
Total 0.034 47         
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Table 18: Total Acetyl Shengmanol Xyloside Content for Each Accession 
 
Table 19: Acetyl Shengmanol Xyloside Raw Values (Weight %) 
Accession 1st 2nd 3rd Average 
Standard 
Deviation 
TN1 0.317 0.222 0.138 0.226 0.089 
46/MO 0.081 0.083 0.135 0.100 0.030 
VA1 0.216 0.215 0.096 0.176 0.068 
PA2 0.111 0.289 0.189 0.196 0.089 
68/AR 0.128 0.255 0.178 0.187 0.064 
DE2 0.266 0.291 0.354 0.304 0.045 
NY1 0.110 0.135 0.121 0.122 0.012 
NY2 0.112 0.156 0.079 0.116 0.038 
WV1 0.146 0.144 0.195 0.162 0.028 
NC2 0.304 0.325 0.384 0.337 0.041 
KY1 0.148 0.114 0.178 0.147 0.032 
IN1 0.329 0.150 0.167 0.216 0.098 
NC3 0.143 0.264 0.170 0.192 0.063 
WV2 0.125 0.194 0.141 0.154 0.036 
PA1 0.210 0.223 0.102 0.178 0.066 
NC4 0.174 0.205 0.234 0.204 0.030 
Table 20: ANOVA Analysis Data for Acetyl Shengmanol Xyloside 
ANOVA 
Source of Variation SS df MS F P-value F crit 
Between Groups 0.178 15 1.18E-01 3.554 0.001 1.991 
Within Groups 0.106 32 3.34E-03    
Total 0.285 47         
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0.4
W
ei
g
h
t %
  (
g
 c
o
m
p
o
u
n
d
/1
00
g
 d
ry
 w
t)
Accession
Acetyl Shengmanol Xyloside Weight % By 
Accession
Error Bar = ±1 SD 
50 
 
 
 
Table 21: Total Caffeic Acid Content for Each Accession 
 
Table 22: Caffeic Acid Raw Values (Weight %) 
Accession 1st 2nd 3rd Average 
Standard 
Deviation 
TN1 0.061 0.057 0.055 0.058 0.003 
46/MO 0.037 0.052 0.034 0.041 0.009 
VA1 0.044 0.050 0.039 0.045 0.005 
PA2 0.036 0.047 0.040 0.041 0.005 
68/AR 0.045 0.042 0.056 0.048 0.007 
DE2 0.044 0.050 0.038 0.044 0.006 
NY1 0.032 0.036 0.044 0.037 0.006 
NY2 0.022 0.044 0.030 0.032 0.011 
WV1 0.033 0.039 0.031 0.035 0.004 
NC2 0.088 0.055 0.050 0.064 0.020 
KY1 0.039 0.040 0.049 0.046 0.005 
IN1 0.040 0.058 0.039 0.046 0.010 
NC3 0.037 0.041 0.067 0.048 0.016 
WV2 0.032 0.052 0.046 0.043 0.009 
PA1 0.050 0.040 0.037 0.042 0.006 
NC4 0.055 0.042 0.083 0.060 0.021 
Table 23: ANOVA Analysis Data for Caffeic Acid 
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ANOVA 
Source of Variation SS df MS F P-value F crit 
Between Groups 0.003 15 2.32E-04 1.985 0.050 1.991 
Within Groups 0.004 32 1.17E-04    
Total 0.007 47         
Error Bar = ±1 SD 
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Table 24: Total Ferulic Acid Content for Each Accession 
 
Table 25: Ferulic Acid Raw Values (Weight %) 
Accession 1st 2nd 3rd Average 
Standard 
Deviation 
TN1 0.052 0.066 0.043 0.054 0.011 
46/MO 0.031 0.029 0.026 0.029 0.002 
VA1 0.069 0.044 0.041 0.051 0.015 
PA2 0.054 0.047 0.052 0.051 0.003 
68/AR 0.041 0.037 0.036 0.038 0.002 
DE2 0.054 0.065 0.062 0.060 0.005 
NY1 0.039 0.054 0.050 0.048 0.007 
NY2 0.064 0.051 0.040 0.052 0.011 
WV1 0.041 0.062 0.071 0.058 0.015 
NC2 0.047 0.041 0.038 0.042 0.004 
KY1 0.043 0.040 0.037 0.040 0.002 
IN1 0.030 0.031 0.033 0.031 0.001 
NC3 0.030 0.030 0.045 0.035 0.008 
WV2 0.058 0.057 0.049 0.055 0.004 
PA1 0.041 0.037 0.050 0.043 0.006 
NC4 0.041 0.056 0.043 0.047 0.008 
Table 26: ANOVA Analysis Data for Ferulic Acid 
ANOVA 
Source of Variation SS df MS F P-value F crit 
Between Groups 0.004 15 2.65E-04 3.822 7.06E04 1.991 
Within Groups 0.002 32 6.92E-05    
Total 0.006 47         
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Table 27: Total Isoferulic Acid Content for Each Accession 
 
Table 28: Isoferulic Acid Raw Values (Weight %) 
Accession 1st 2nd 3rd Average 
Standard 
Deviation 
TN1 0.071 0.0512 0.070 0.064 0.011 
46/MO 0.071 0.0729 0.078 0.074 0.004 
VA1 0.057 0.0720 0.068 0.066 0.007 
PA2 0.054 0.0500 0.038 0.047 0.008 
68/AR 0.059 0.1033 0.066 0.076 0.023 
DE2 0.051 0.0361 0.093 0.060 0.029 
NY1 0.060 0.0428 0.049 0.050 0.009 
NY2 0.051 0.0608 0.052 0.054 0.005 
WV1 0.070 0.0605 0.065 0.065 0.005 
NC2 0.037 0.0355 0.048 0.040 0.006 
KY1 0.056 0.0615 0.056 0.057 0.003 
IN1 0.065 0.0653 0.090 0.073 0.014 
NC3 0.065 0.0615 0.050 0.059 0.007 
WV2 0.050 0.0692 0.061 0.060 0.009 
PA1 0.074 0.0692 0.055 0.066 0.009 
NC4 0.081 0.0790 0.095 0.085 0.008 
Table 29: ANOVA Analysis Data for Isoferulic Acid 
ANOVA 
Source of Variation SS df MS F P-value F crit 
Between Groups 0.006 15 0.0004 2.582 0.012 1.991 
Within Groups 0.004 32 0.0002    
Total 0.011 47         
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Table 30: ANOVA Data for Subset (IN1, PA1, NY2, NC3, KY1, DE2) Analysis of 
Actein and 23-epi-26-deoxyactein 
ANOVA 
      Source of Variation SS df MS F P-value F crit 
Between Groups 0.024 5 0.0048 0.368 0.860 3.105 
Within Groups 0.156 12 0.0130 
   Total 0.180          17         
 
Figure 5: ESI(+ Mode) Mass Spectrum of Cimiracemoside A 
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Figure 6: Proton NMR Spectrum of Cimiracemoside A 
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Figure 7: Carbon NMR Spectrum of Cimiracemoside A 
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Figure 8: ESL (+ Mode) Mass Spectrum of Cimiracemoside C 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
57 
 
 
 
Figure 9: Proton NMR Spectrum of Cimiracemoside C 
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Figure 10: Carbon NMR Spectrum of Cimiracemoside C 
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Figure 11: ESI (+ Mode) Mass Spectrum of Cimigenol Xyloside 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
60 
 
 
 
Figure 12: Proton NMR Spectrum of Cimigenol Xyloside 
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Figure 13: Carbon NMR Spectrum of Cimigenol Xyloside 
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Figure 14: ESI (+ Mode) Mass Spectrum of Acetyl Shengmanol Xyloside 
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Figure 15: Proton NMR Spectrum of Acetyl Shengmanol Xyloside 
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Figure 16: Carbon NMR Spectrum of Acetyl Shengmanol Xyloside 
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Figure 17: Sample Saponin HPLC-ELSD Chromatogram 
 
 
 
 
Figure 18: Zoom in of Sample Saponin Chromatogram 
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Figure 19: Sample Phenolic Acids Chromatogram 
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Figure 20: Zoom in of Sample Phenolic Acids Chromatogram 
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Figure 21: Fractionation Tree for Black Cohosh
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106A069B
Take 444.97 mg
Silica Gel OCC
Step gradient:
19:1, 9:1, 4:1, 2:1
CHCl3:MeOH-
100% MeOH
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ID: 106A-
Mass (mg):
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21.72
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CHCl3:MeOH CHCl3:MeOH CHCl3:MeOHCHCl3:MeOH
100% MeOH
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Mass (mg):
Prep HPLC Isolation
35% ACN isocratic
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Acetyl Shengmanol Xyloside
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